Risk factors for functional limitations in patients with long-standing ankylosing spondylitis

被引:103
作者
Ward, MM
Weisman, MH
Davis, JC
Reveille, JD
机构
[1] NIAMS, US Dept Hlth & Human Serv, NIH, Bethesda, MD 20892 USA
[2] Cedars Sinai Med Ctr, Los Angeles, CA 90048 USA
[3] Univ Calif San Francisco, San Francisco, CA 94143 USA
[4] Univ Texas, Hlth Sci Ctr, Houston, TX USA
来源
ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH | 2005年 / 53卷 / 05期
关键词
ankylosing spondylitis; disability; functional limitations; work;
D O I
10.1002/art.21444
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective. To identify risk factors for functional limitations in patients with ankylosing spondylitis (AS) of at least 20 years' duration. Methods. Patients with AS for >= 20 years were enrolled in the cross-sectional component of the Prospective Study of Outcomes in AS. All patients had clinical evaluations and completed questionnaires on functional limitations and potential risk factors. Functional limitations were assessed using the Bath Ankylosing Spondylitis. Functional Index (BASFI; score range 0-100, higher scores indicate more limitations) and the Health Assessment Questionnaire for the Spondylarthropathies (HAQS). Risk factors included demographic characteristics, duration of AS, smoking status, number of comorbid medical conditions, recalled level of recreational activity in teens and twenties, occupational physical activity throughout life (rated 1 = little, 2 = moderate, 3 = heavy, and weighted by the number of years in each job), and history of AS in a first-degree relative. Results. The 326 patients (74% men) had a mean +/- SD age of 55.0 +/- 10.7 years, a mean duration of AS symptoms of 31.7 +/- 10.2 years, and a mean BASFI score of 40.7 +/- 25.6. BASFI scores increased with higher lifetime occupational physical activity (r = 0.31; P < 0.0001), the number of comorbid conditions (r = 0.25; P < 0.0001), and the duration of AS (r = 0.12; P = 0.04). BASFI scores were higher among current smokers compared with former/nonsmokers (55.5 versus 38.9; P = 0.0002), and among nonwhites compared with whites (49.9 versus 39.3; P = 0.02). In multivariable analyses, lifetime occupational physical activity, current smoking, education level, number of comorbid conditions, and family history were significantly associated with BASFI scores. The same risk factors were associated with the HAAS. Conclusion. Functional limitations in patients with AS for >= 20 years are greater among those with a history of more physically demanding jobs, more comorbid conditions, and among smokers, and are less severe among those with higher levels of education and a family history of AS.
引用
收藏
页码:710 / 717
页数:8
相关论文
共 40 条
  • [1] Physical function and health-related quality of life of Spanish patients with ankylosing spondylitis
    Ariza-Ariza, R
    Hernández-Cruz, B
    Navarro-Sarabia, F
    [J]. ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH, 2003, 49 (04): : 483 - 487
  • [2] Smoking and outcome in ankylosing spondylitis
    Averns, HL
    Oxtoby, J
    Taylor, HG
    Jones, PW
    Dziedzic, K
    Dawes, PT
    [J]. SCANDINAVIAN JOURNAL OF RHEUMATOLOGY, 1996, 25 (03) : 138 - 142
  • [3] BAKKER C, 1995, J RHEUMATOL, V22, P1304
  • [4] Barlow JH, 2001, ARTHRIT RHEUM-ARTHR, V45, P424, DOI 10.1002/1529-0131(200110)45:5<424::AID-ART361>3.0.CO
  • [5] 2-7
  • [6] Costs of ankylosing spondylitis in three European countries:: the patient's perspective
    Boonen, A
    van der Heijde, D
    Landewé, R
    Guillemin, F
    Spoorenberg, A
    Schouten, H
    Rutten-van Mölken, M
    Dougados, M
    Mielants, H
    de Vlam, K
    van der Tempel, H
    van der Linden, S
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2003, 62 (08) : 741 - 747
  • [7] Withdrawal from labour force due to work disability in patients with ankylosing spondylitis
    Boonen, A
    Chorus, A
    Miedema, H
    van der Heijde, D
    Landewé, R
    Schouten, H
    van der Tempel, H
    van der Linden, S
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2001, 60 (11) : 1033 - 1039
  • [8] Boonen A, 2001, J RHEUMATOL, V28, P1056
  • [9] Treatment of active ankylosing spondylitis with infliximab:: a randomised controlled multicentre trial
    Braun, J
    Brandt, J
    Listing, J
    Zink, A
    Alten, R
    Golder, W
    Gromica-Ihle, E
    Kellner, H
    Krause, A
    Schneider, M
    Sörensen, H
    Zeidler, H
    Thriene, W
    Sieper, J
    [J]. LANCET, 2002, 359 (9313) : 1187 - 1193
  • [10] CALIN A, 1988, J RHEUMATOL, V15, P1234